Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 4/20 | 0.54 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.54 |
| ▸ | BDKRB2 | P30411 | 4/20 | 0.51 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.48 |
| ▸ | ACE | P12821 | 1/20 | 0.48 |
| ▸ | REN | P00797 | 1/20 | 0.48 |
| ▸ | CALCRL | Q16602 | 2/20 | 0.48 |
| ▸ | EPHA2 | P29317 | 2/20 | 0.47 |
| ▸ | AKT1 | P31749 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29856163 | 0.84 | SLC6A2 (0.58) | OPRM1OPRD1SLC6A2ACEREN | |
| SCHEMBL31182919 | 0.83 | KEAP1 (0.54) | CALCRL | |
| SCHEMBL29512206 | 0.82 | CALCRL (0.49) | OPRM1OPRD1ACECALCRL | |
| SCHEMBL30475332 | 0.82 | OPRM1 (0.59) | OPRM1OPRD1BDKRB2SLC6A2REN | |
| SCHEMBL31390815 | 0.82 | SLC6A2 (0.56) | OPRM1OPRD1SLC6A2RENCALCRL | |
| SCHEMBL11284539 | 0.81 | OPRM1 (0.52) | OPRM1OPRD1EPHA2AKT1 | |
| SCHEMBL11284534 | 0.81 | OPRM1 (0.52) | OPRM1OPRD1EPHA2AKT1 | |
| SCHEMBL29695544 | 0.81 | CALCRL (0.58) | SLC6A2ACERENCALCRL | |
| SCHEMBL30311985 | 0.81 | KEAP1 (0.49) | OPRD1SLC6A2RENCALCRL | |
| SCHEMBL30311937 | 0.81 | CMA1 (0.51) | OPRM1OPRD1SLC6A2REN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111378638-B | Helicobacter pylori phage lyase and preparation method thereof | 江苏万邦医药科技有限公司 | 2023-05-05 | — | — | CN | disclosed |